Belimumab was recently approved for treatment of lupus glomerulonephritis (LN).
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
Saccon, Francesca;Larosa, Maddalena;Orsolini, Giovanni;Rossini, Maurizio;
2021-01-01
Abstract
Belimumab was recently approved for treatment of lupus glomerulonephritis (LN).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
